Cefaly Technology
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Cefaly Technology sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Cefaly Technology: 7 sponsored US clinical trials, 1 recruiting.
Cefaly Technology sponsors 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 6 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Migraine, with 3 trials.
Upper-quartile sponsor footprint
Cefaly Technology sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy
NCT06788977
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
NCT03465904
Abortive Treatment of Migraine With the Cefaly® Abortive Program Device
NCT03217968
Acute Treatment of Migraine With e-TNS
NCT02590939
Cefaly® Device in the Treatment of Patients With Fibromyalgia.
NCT02546362
Acute Treatment of Migraine Using the CEFALY Device
NCT02411513
Open-trial on the Prevention of Chronic Migraines With the CEFALY Device
NCT02342743
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Therapeutic Areas
What is open in the Cefaly Technology pipeline
1 recruiting of 7 indexed (14% open); 6 completed (86%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Migraine (3 trials), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Cefaly Technology: open-pipeline peers nationwide
Peers matched on 7 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Cefaly Technology sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Cefaly Technology page
7 registered trials is a research-attention snapshot, not an endorsement of Cefaly Technology or any single study.
- 1 of Cefaly Technology's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Migraine is the condition Cefaly Technology studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Migraine trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Cefaly Technology pipeline card: 7 registered trials from official public datasets.Report a data error.